Study Of An Investigational Drug For People Receiving Disease Modifying Therapy For Relapsing Multiple Sclerosis
Seeking men and women aged 18 to 65 with relapsing multiple sclerosis who have either not started, or have discontinued treatment with a disease modifying therapy for a study of an investigational drug.